PL4161505T3 - Kompozycja do normalizacji stłuszczenia wątroby i sposób jej wytwarzania - Google Patents
Kompozycja do normalizacji stłuszczenia wątroby i sposób jej wytwarzaniaInfo
- Publication number
- PL4161505T3 PL4161505T3 PL21818356.4T PL21818356T PL4161505T3 PL 4161505 T3 PL4161505 T3 PL 4161505T3 PL 21818356 T PL21818356 T PL 21818356T PL 4161505 T3 PL4161505 T3 PL 4161505T3
- Authority
- PL
- Poland
- Prior art keywords
- normalisation
- producing
- composition
- same
- fatty liver
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Meat, Egg Or Seafood Products (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2020002852A MY210343A (en) | 2020-06-04 | 2020-06-04 | Composition for normalisation of fatty liver and method for producing the same |
| PCT/MY2021/050043 WO2021246861A1 (en) | 2020-06-04 | 2021-06-03 | Composition for normalisation of fatty liver and method for producing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4161505T3 true PL4161505T3 (pl) | 2026-01-19 |
Family
ID=78830522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21818356.4T PL4161505T3 (pl) | 2020-06-04 | 2021-06-03 | Kompozycja do normalizacji stłuszczenia wątroby i sposób jej wytwarzania |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4161505B8 (pl) |
| AU (1) | AU2021283774A1 (pl) |
| ES (1) | ES3054078T3 (pl) |
| MY (1) | MY210343A (pl) |
| PL (1) | PL4161505T3 (pl) |
| WO (1) | WO2021246861A1 (pl) |
| ZA (1) | ZA202213079B (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY203355A (en) * | 2021-12-27 | 2024-06-25 | Sd Guthrie Intellectual Property Sdn Bhd | Self-emulsifying composition |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9514878D0 (en) * | 1995-07-20 | 1995-09-20 | Danbiosyst Uk | Vitamin E as a solubilizer for drugs contained in lipid vehicles |
| WO2002026324A2 (en) * | 2000-09-27 | 2002-04-04 | Sonus Pharmaceuticals, Inc. | Tocol-based compositions containing amiodarone |
| TWI759260B (zh) * | 2015-01-02 | 2022-04-01 | 美商梅拉洛伊卡公司 | 多元補充品組成物 |
| CN105983013A (zh) * | 2015-03-23 | 2016-10-05 | 天士力制药集团股份有限公司 | 一种含有水飞蓟宾、葛根提取物的药物组合物 |
| MY192213A (en) * | 2016-05-23 | 2022-08-08 | Attest Res Sdn Bhd | A composition for preventing or mitigating dementia |
| CN107320468A (zh) * | 2017-07-05 | 2017-11-07 | 刘彦博 | 复合磷脂脂质体口服液及其制备方法和应用 |
| JP7379348B2 (ja) * | 2017-10-11 | 2023-11-14 | バスト バイオテクノロジー | 線維症の治療のための組成物および方法 |
-
2020
- 2020-06-04 MY MYPI2020002852A patent/MY210343A/en unknown
-
2021
- 2021-06-03 AU AU2021283774A patent/AU2021283774A1/en active Pending
- 2021-06-03 EP EP21818356.4A patent/EP4161505B8/en active Active
- 2021-06-03 WO PCT/MY2021/050043 patent/WO2021246861A1/en not_active Ceased
- 2021-06-03 ES ES21818356T patent/ES3054078T3/es active Active
- 2021-06-03 PL PL21818356.4T patent/PL4161505T3/pl unknown
-
2022
- 2022-12-02 ZA ZA2022/13079A patent/ZA202213079B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2021283774A1 (en) | 2023-01-19 |
| EP4161505B1 (en) | 2025-09-03 |
| MY210343A (en) | 2025-09-12 |
| ZA202213079B (en) | 2024-09-25 |
| EP4161505A1 (en) | 2023-04-12 |
| EP4161505B8 (en) | 2025-11-26 |
| ES3054078T3 (en) | 2026-01-29 |
| EP4161505C0 (en) | 2025-09-03 |
| WO2021246861A1 (en) | 2021-12-09 |
| EP4161505A4 (en) | 2024-06-12 |
| TW202146003A (zh) | 2021-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3635095A4 (en) | LIVER ORGANOID COMPOSITIONS AND METHOD FOR MANUFACTURING AND USING THEREOF | |
| IL304214A (en) | Preparations and methods for the treatment of metabolic and liver disorders | |
| PL4036143T3 (pl) | Dwuczęściowa epoksydowa kompozycja elastomerowa zawierająca ester fosforanowy i sposób jej stosowania | |
| GB202011871D0 (en) | Composition and method | |
| IL309043A (en) | Crystalline Abdenase compositions and methods for their preparation and use | |
| PL4161505T3 (pl) | Kompozycja do normalizacji stłuszczenia wątroby i sposób jej wytwarzania | |
| AU2021347431B2 (en) | Method of treating fatty liver disease | |
| GB2593010B (en) | Composition and Method | |
| GB202100998D0 (en) | Composition and method | |
| GB202100997D0 (en) | Composition and method | |
| LT4027976T (lt) | Rifabutino kompozicijos ir gamybos būdas | |
| GB202013271D0 (en) | Composition and method | |
| GB202010449D0 (en) | Method and composition | |
| EP3616705A4 (en) | COMPOSITION WITH AMOMUM VILLOSUM TO IMPROVE THE PREVENTION AND TREATMENT OF FATTY LIVER | |
| SG11202012283XA (en) | Additive composition and method of preparing the same | |
| GB202109827D0 (en) | Method and composition | |
| GB202102310D0 (en) | Composition and method | |
| GB202016644D0 (en) | Composition and method | |
| IL316459A (en) | Cannabinoid compositions and methods for their production | |
| GB202003327D0 (en) | Beverage composition and method of forming the same | |
| GB202001454D0 (en) | Method and composition of increasing antioxidant | |
| HK40072394A (en) | Shaped organoid compositions and methods of making same | |
| HK40028143A (en) | Liver organoid compositions and methods of making and using same | |
| GB202113086D0 (en) | Composition and method | |
| GB202113085D0 (en) | Composition and method |